$MRAI
Marpai, Inc.

2023 Q1 Form 10-K Financial Statement

#000095017023010614 Filed on March 29, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $9.672M $7.628M $24.34M
YoY Change 55.53% 29.38% 71.1%
Cost Of Revenue $6.409M $4.813M $17.14M
YoY Change 40.95% 13.88% 66.54%
Gross Profit $3.263M $2.816M $7.206M
YoY Change 95.17% 68.6% 83.01%
Gross Profit Margin 33.74% 36.91% 29.6%
Selling, General & Admin $7.406M $9.424M $19.26M
YoY Change 66.0% 55.39% 47.89%
% of Gross Profit 226.94% 334.68% 267.25%
Research & Development $500.2K $1.024M $3.708M
YoY Change -15.66% 66.3% 113.85%
% of Gross Profit 15.33% 36.37% 51.46%
Depreciation & Amortization $1.044M $1.094M $3.538M
YoY Change 26.44% 48.19% 80.36%
% of Gross Profit 31.98% 38.86% 49.1%
Operating Expenses $7.906M $11.54M $22.97M
YoY Change 56.41% 55.57% 55.65%
Operating Profit -$8.523M -$8.727M -$26.96M
YoY Change 53.88% 51.79% 69.95%
Interest Expense $385.0K -$254.3K $266.8K
YoY Change 9659.44% 494.2% -37.55%
% of Operating Profit
Other Income/Expense, Net $50.45K $138.9K $234.5K
YoY Change 2.97% 118.93% 35.92%
Pretax Income -$8.873M -$9.055M -$26.99M
YoY Change 61.63% 58.07% 67.27%
Income Tax $0.00 -$521.1K -$521.1K
% Of Pretax Income
Net Earnings -$8.900M -$8.534M -$26.47M
YoY Change 62.12% 48.97% 65.58%
Net Earnings / Revenue -92.02% -111.87% -108.74%
Basic Earnings Per Share -$0.42 -$1.31
Diluted Earnings Per Share -$0.42 -$0.41 -$1.31
COMMON SHARES
Basic Shares Outstanding 21.41M 20.94M 20.24M
Diluted Shares Outstanding 21.16M 20.24M

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.175M $13.76M $13.76M
YoY Change -56.23% -28.25% -28.25%
Cash & Equivalents $6.200M $13.76M $13.76M
Short-Term Investments
Other Short-Term Assets $11.83M $10.95M $10.95M
YoY Change 38.04% 46.18% 46.18%
Inventory
Prepaid Expenses
Receivables $963.1K $1.438M $1.788M
Other Receivables $45.60K $30.63K $30.63K
Total Short-Term Assets $20.08M $26.54M $26.54M
YoY Change -12.24% -1.68% -1.68%
LONG-TERM ASSETS
Property, Plant & Equipment $1.345M $1.506M $5.348M
YoY Change 45.75% 69.24% 82.3%
Goodwill $5.873M $5.837M
YoY Change 146.46% 144.95%
Intangibles $6.049M $6.323M
YoY Change 14.41% 14.81%
Long-Term Investments
YoY Change
Other Assets $21.67K $21.67K $1.315M
YoY Change -73.12% -73.12% 1531.1%
Total Long-Term Assets $22.15M $23.41M $23.41M
YoY Change 32.2% 36.04% 36.04%
TOTAL ASSETS
Total Short-Term Assets $20.08M $26.54M $26.54M
Total Long-Term Assets $22.15M $23.41M $23.41M
Total Assets $42.23M $49.95M $49.95M
YoY Change 6.54% 13.0% 13.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.111M $1.458M $1.458M
YoY Change 98.29% 29.47% 29.47%
Accrued Expenses $3.769M $5.275M $15.61M
YoY Change 73.39% 108.9% 76.38%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $17.46M $17.36M $17.36M
YoY Change 45.88% 55.76% 55.76%
LONG-TERM LIABILITIES
Long-Term Debt $20.59M $0.00 $0.00
YoY Change
Other Long-Term Liabilities $20.59M $20.20M $24.98M
YoY Change 45659.44% 44797.11% 1754.4%
Total Long-Term Liabilities $20.59M $20.20M $24.98M
YoY Change 45659.44% 44797.11% 1754.4%
TOTAL LIABILITIES
Total Short-Term Liabilities $17.46M $17.36M $17.36M
Total Long-Term Liabilities $20.59M $20.20M $24.98M
Total Liabilities $44.14M $43.82M $43.82M
YoY Change 191.04% 202.32% 202.32%
SHAREHOLDERS EQUITY
Retained Earnings -$56.90M -$47.99M
YoY Change 110.62% 122.96%
Common Stock $2.161K $2.128K
YoY Change 6.45% 4.83%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.911M $6.134M $6.134M
YoY Change
Total Liabilities & Shareholders Equity $42.23M $49.95M $49.95M
YoY Change 6.54% 13.0% 13.0%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$8.900M -$8.534M -$26.47M
YoY Change 62.12% 48.97% 65.58%
Depreciation, Depletion And Amortization $1.044M $1.094M $3.538M
YoY Change 26.44% 48.19% 80.36%
Cash From Operating Activities -$6.500M -$19.90M -$35.24M
YoY Change 95.33% 277.71% 226.43%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $85.54K $362.8K
YoY Change -100.0% -118.51% 32.67%
Acquisitions
YoY Change
Other Investing Activities $3.210K $33.39M $33.39M
YoY Change 193.29%
Cash From Investing Activities $3.213K $33.30M $32.42M
YoY Change -100.65% -7305.71% 236.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 221.0 200.0 196.0
YoY Change -100.0% -100.0%
NET CHANGE
Cash From Operating Activities -6.500M -19.90M -35.24M
Cash From Investing Activities 3.213K 33.30M 32.42M
Cash From Financing Activities 221.0 200.0 196.0
Net Change In Cash -6.536M 13.40M -2.817M
YoY Change 71.01% -20.85% -111.68%
FREE CASH FLOW
Cash From Operating Activities -$6.500M -$19.90M -$35.24M
Capital Expenditures $0.00 $85.54K $362.8K
Free Cash Flow -$6.500M -$19.99M -$35.60M
YoY Change 89.57% 315.8% 221.65%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001844392
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-40904
CY2022 dei Entity Registrant Name
EntityRegistrantName
MARPAI INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-1916231
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
5701 East Hillsborough Ave., Suite 1417
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Tampa
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33610-5428
CY2022 dei City Area Code
CityAreaCode
646
CY2022 dei Local Phone Number
LocalPhoneNumber
303-3483
CY2022 dei Security12b Title
Security12bTitle
Common Shares, par value $0.0001
CY2022 dei Trading Symbol
TradingSymbol
MRAI
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
4875220
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
21412580
CY2022 dei Auditor Name
AuditorName
UHY LLP
CY2022 dei Auditor Firm
AuditorFirmId
1195
CY2022 dei Auditor Location
AuditorLocation
Melville, New York
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13764508
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19183044
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
9352608
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
6750599
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
23458
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1437786
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
208762
CY2022Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
350393
CY2021Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
14978
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1601920
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
743126
CY2022Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
30634
CY2021Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
91498
CY2022Q4 us-gaap Assets Current
AssetsCurrent
26537849
CY2021Q4 us-gaap Assets Current
AssetsCurrent
26992007
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1506082
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
889935
CY2022Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
4588706
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
6304854
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3841810
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2043624
CY2022Q4 us-gaap Goodwill
Goodwill
5837060
CY2021Q4 us-gaap Goodwill
Goodwill
2382917
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6323279
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5507693
CY2022Q4 us-gaap Security Deposit
SecurityDeposit
1293166
CY2021Q4 us-gaap Security Deposit
SecurityDeposit
52277
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
21668
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
28333
CY2022Q4 us-gaap Assets
Assets
49949620
CY2021Q4 us-gaap Assets
Assets
44201640
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1457670
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1125906
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5274716
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2525037
CY2022Q4 mrai Accrued Fiduciary Obligations Current
AccruedFiduciaryObligationsCurrent
9024463
CY2021Q4 mrai Accrued Fiduciary Obligations Current
AccruedFiduciaryObligationsCurrent
5541067
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
288499
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1165248
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1311295
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
784493
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
3201
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
3637
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
17359844
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11145388
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
20203700
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
45000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4771871
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1301828
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1479880
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2001012
CY2022Q4 us-gaap Liabilities
Liabilities
43815295
CY2021Q4 us-gaap Liabilities
Liabilities
14493228
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
227791050
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
227791050
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21279032
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21279032
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20299727
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20299727
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
2128
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
2030
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
54126297
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
51232092
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-47994100
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-21525710
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
6134325
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
29708412
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
49949620
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
44201640
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24341874
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14226794
CY2022 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
17136330
CY2021 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
10289578
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12318529
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8055572
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6938513
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4965209
CY2022 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
6372795
CY2021 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
2492060
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3708068
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1733964
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3538237
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1961733
CY2022 mrai Facilities Expense
FacilitiesExpense
1012827
CY2021 mrai Facilities Expense
FacilitiesExpense
589926
CY2022 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-273430
CY2022 us-gaap Costs And Expenses
CostsAndExpenses
51298729
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
30088042
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-26956855
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-15861248
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
234472
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
172513
CY2022 us-gaap Interest Expense
InterestExpense
266778
CY2021 us-gaap Interest Expense
InterestExpense
427178
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-361
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-18922
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-26989522
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16134835
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-521132
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-150000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-26468390
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-15984835
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.31
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.31
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.59
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.59
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20239837
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20239837
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10076494
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10076494
CY2021Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
4.555821
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-3496499
CY2021 mrai Stock Issued During Period Value Exchange With Subsidiary
StockIssuedDuringPeriodValueExchangeWithSubsidiary
-14
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
17351935
CY2021 mrai Stock Issued During Period Value Ipo
StockIssuedDuringPeriodValueIpo
24547085
CY2021 mrai Stock Issued During Period Value Conversion Of Convertible Notes To Common Stock
StockIssuedDuringPeriodValueConversionOfConvertibleNotesToCommonStock
5106554
CY2021 mrai Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
900000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
61
CY2021 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
53333
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1230792
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-15984835
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
29708412
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2855385
CY2022 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
85
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
38627
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
206
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-26468390
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
6134325
CY2021Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
4.555821
CY2022 us-gaap Profit Loss
ProfitLoss
-26468390
CY2021 us-gaap Profit Loss
ProfitLoss
-15984835
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3538237
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1961733
CY2022 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-273430
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
3105385
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
1230792
CY2022 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
38623
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
598925
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
100160
CY2021 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
26728
CY2022 us-gaap Paid In Kind Interest
PaidInKindInterest
258787
CY2021 us-gaap Paid In Kind Interest
PaidInKindInterest
365880
CY2021 mrai Convertible Notes Issued In Exchange For Services
ConvertibleNotesIssuedInExchangeForServices
-75000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-521132
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-150000
CY2022 mrai Increase Decrease In Accounts Receivable And Unbilled Receivable
IncreaseDecreaseInAccountsReceivableAndUnbilledReceivable
597051
CY2021 mrai Increase Decrease In Accounts Receivable And Unbilled Receivable
IncreaseDecreaseInAccountsReceivableAndUnbilledReceivable
131509
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-892577
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
349502
CY2022 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-60864
CY2021 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-8540
CY2021 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
2592
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
181436
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
41130
CY2021 mrai Increase Decrease In Accounts Payable Related Party
IncreaseDecreaseInAccountsPayableRelatedParty
-15725
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2052232
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
961795
CY2022 mrai Increase Decrease In Accrued Fiduciary Obligations
IncreaseDecreaseInAccruedFiduciaryObligations
12823139
CY2021 mrai Increase Decrease In Accrued Fiduciary Obligations
IncreaseDecreaseInAccruedFiduciaryObligations
-1470159
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-661382
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-99884
CY2022 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-2805
CY2021 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-240001
CY2022 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1068098
CY2021 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-39972
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-6666
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
28333
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-35239299
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10795252
CY2022 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
33388149
CY2021 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
11384035
CY2022 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
602805
CY2021 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1463812
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
3050
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
362768
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
273433
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
32422576
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
9643740
CY2021 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
25378663
CY2021 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
900000
CY2021 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
783257
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
196
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
61
CY2021 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
550000
CY2021 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
3000000
CY2021 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
3000000
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
831577
CY2021 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
53333
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
196
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25267223
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2816527
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
24115711
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25933643
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1817932
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23117116
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25933643
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13764508
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19183044
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
9352608
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
6750599
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23117116
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25933643
CY2021 mrai Conversion Of Convertible Notes Into Common Stock At Closing Of Acquisition
ConversionOfConvertibleNotesIntoCommonStockAtClosingOfAcquisition
4089921
CY2021 mrai Conversion Of Convertible Notes Into Common Stock At Ipo
ConversionOfConvertibleNotesIntoCommonStockAtIpo
5106554
CY2021 mrai Payments Of Non Cash Activity On Office Improvements
PaymentsOfNonCashActivityOnOfficeImprovements
27567
CY2021 us-gaap Stock Issued1
StockIssued1
8500000
CY2022 mrai Long Term Liability Incurred In Connection With The Acquisition
LongTermLiabilityIncurredInConnectionWithTheAcquisition
19900000
CY2021Q1 mrai Number Of Healthcare Subsidiaries
NumberOfHealthcareSubsidiaries
2
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-47994100
CY2022Q4 mrai Working Capital
WorkingCapital
9178005
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
20203700
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13764508
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-left:6.267%;text-indent:0.0%;font-size:10.0pt;margin-top:11.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:6.269%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Use of Estimates</span></p><p style="margin-left:6.267%;text-indent:0.0%;font-size:10.0pt;margin-top:11.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:6.269%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of the accompanying consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingencies at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Such estimates include, but are not limited to, valuation of share-based compensation, valuation of the Company’s common stock prior to the IPO, accounting for warrants, allowance for doubtful accounts, useful lives of internally developed software, fair values of net assets acquired, goodwill, intangible assets and property and equipment, whether an arrangement is or contains a lease, the incremental borrowing rate used for operating leases, income tax accruals, the valuation allowance for deferred income taxes, and contingent liabilities.</span></p><p style="margin-left:6.267%;text-indent:0.0%;font-size:10.0pt;margin-top:11.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:6.269%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that it believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ from those estimates.</span></p>
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-left:6.267%;text-indent:0.0%;font-size:10.0pt;margin-top:11.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:6.269%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Concentrations of Credit Risk</span></p><p style="margin-left:6.267%;text-indent:0.0%;font-size:10.0pt;margin-top:11.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:6.269%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company maintains cash accounts with financial institutions. At times, balances in these accounts may exceed federally insured limits. The amounts over the federally insured limits as of December 31, 2022 and 2021 was approximately $</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,137,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,777,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively. </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> losses have been incurred to date on any deposit balances.</span></p><p style="margin-left:6.267%;text-indent:0.0%;font-size:10.0pt;margin-top:11.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:6.269%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the years ended December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> customer accounted for greater than 10% of total revenue. At December 31, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">one</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> customer accounted for </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of accounts receivable. At December 31, 2021, </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">three</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> customers accounted for </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">43</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%, </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%, and </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of accounts receivable, respectively.</span></p>
CY2022Q4 mrai Amounts Over Federally Insured Limits
AmountsOverFederallyInsuredLimits
13137000
CY2021Q4 mrai Amounts Over Federally Insured Limits
AmountsOverFederallyInsuredLimits
18777000
CY2022 mrai Losses Incurred To Date On Deposit Balances
LossesIncurredToDateOnDepositBalances
0
CY2022 mrai Number Of Customers Who Accounted For Greater Than Ten Percent Of Revenue
NumberOfCustomersWhoAccountedForGreaterThanTenPercentOfRevenue
0
CY2021 mrai Number Of Customers Who Accounted For Greater Than Ten Percent Of Revenue
NumberOfCustomersWhoAccountedForGreaterThanTenPercentOfRevenue
0
CY2022 mrai Number Of Customers Who Accounted For Greater Than Ten Percent Of Accounts Receivable
NumberOfCustomersWhoAccountedForGreaterThanTenPercentOfAccountsReceivable
1
CY2021 mrai Number Of Customers Who Accounted For Greater Than Ten Percent Of Accounts Receivable
NumberOfCustomersWhoAccountedForGreaterThanTenPercentOfAccountsReceivable
3
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
23458
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2022 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2021 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2022 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2022 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2021 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
1437786
CY2021Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
208762
CY2022Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
350393
CY2021Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
14978
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
288499
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1165248
CY2022Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
244029
CY2021Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
418988
CY2022 mrai Accounts Receivable Payments Term
AccountsReceivablePaymentsTerm
P30D
CY2022 mrai Warrants To Acquire Common Shares
WarrantsToAcquireCommonShares
<p style="margin-left:6.267%;text-indent:0.0%;font-size:10.0pt;margin-top:11.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:6.269%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrants to Acquire Common Shares:</span></p><p style="margin-left:6.267%;text-indent:0.0%;font-size:10.0pt;margin-top:11.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:6.269%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company accounts for common stock warrants as either equity-classified or liability classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480 “Distinguishing Liabilities from Equity” ("ASC 480") and ASC 815 “Derivatives and Hedging” ("ASC 580"). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, whether the warrants meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common stock and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3831720
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2556119
CY2022 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2022 mrai Lease Expiration Ending Year
LeaseExpirationEndingYear
2030
CY2022 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2022 us-gaap Lessee Operating Lease Existence Of Option To Terminate
LesseeOperatingLeaseExistenceOfOptionToTerminate
true
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
1117193
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
666830
CY2022 us-gaap Advertising Expense
AdvertisingExpense
80925
CY2021 us-gaap Advertising Expense
AdvertisingExpense
1261296
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2155827
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1185518
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
649745
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
295583
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1506082
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
889935
CY2022 us-gaap Depreciation
Depreciation
397470
CY2021 us-gaap Depreciation
Depreciation
199649
CY2022Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
8094385
CY2021Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
7161571
CY2022Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
3505679
CY2021Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
1186727
CY2022Q4 mrai Capitalized Computer Software Net Of Accumulated Amortization And In Process
CapitalizedComputerSoftwareNetOfAccumulatedAmortizationAndInProcess
4588706
CY2021Q4 mrai Capitalized Computer Software Net Of Accumulated Amortization And In Process
CapitalizedComputerSoftwareNetOfAccumulatedAmortizationAndInProcess
5974844
CY2021Q4 mrai Capitalized Computer Software In Process
CapitalizedComputerSoftwareInProcess
330010
CY2022Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
4588706
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
6304854
CY2022 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
2318953
CY2021 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
1186727
CY2021Q4 us-gaap Goodwill
Goodwill
2382917
CY2022 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
3454143
CY2022Q4 us-gaap Goodwill
Goodwill
5837060
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
821814
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
575357
CY2022 mrai Lease Expiration Beginning Year
LeaseExpirationBeginningYear
2023
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1885604
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1098134
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1108012
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1088112
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
939600
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
1961640
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
8081102
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1997936
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
6083166
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1311295
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4771871
CY2022Q4 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P5Y10M24D
CY2021Q4 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P2Y7M6D
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0911
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.060
CY2022 us-gaap Sublease Income
SubleaseIncome
196465
CY2021 us-gaap Sublease Income
SubleaseIncome
172476
CY2022Q4 mrai Lessee Operating Lease Amount Contractual To Receive Year One
LesseeOperatingLeaseAmountContractualToReceiveYearOne
151355
CY2022Q4 mrai Lessee Operating Lease Amount Contractual To Receive
LesseeOperatingLeaseAmountContractualToReceive
151355
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2699263
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.204
CY2022 mrai Effective Income Tax Rate Reconciliation Change In Deferred Tax Liability
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxLiability
0.019
CY2022 mrai Effective Income Tax Rate Reconciliation Permanent Differences Percent
EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent
-0.014
CY2022Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
4.00
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1648873
CY2021Q4 mrai Warrants Weighted Average Exercise Price
WarrantsWeightedAverageExercisePrice
5.92
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.019
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.009
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.002
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.006
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.019
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.201
CY2021 mrai Effective Income Tax Rate Reconciliation Return To Provision Adjustments Percent
EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentsPercent
-0.005
CY2021 mrai Effective Income Tax Rate Reconciliation Permanent Differences Percent
EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent
0.005
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.000
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.009
CY2022 mrai Maximum Percentage Of Taxable Income Can Be Utilized For Operating Losses
MaximumPercentageOfTaxableIncomeCanBeUtilizedForOperatingLosses
0.80
CY2022Q4 mrai Deferred Tax Assets Startup Costs
DeferredTaxAssetsStartupCosts
1035317
CY2021Q4 mrai Deferred Tax Assets Startup Costs
DeferredTaxAssetsStartupCosts
1001272
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
875498
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
584881
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
6204900
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
2244367
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
1264598
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
522491
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
174289
CY2022Q4 mrai Deferred Tax Assets Amortization
DeferredTaxAssetsAmortization
1217409
CY2021Q4 mrai Deferred Tax Assets Amortization
DeferredTaxAssetsAmortization
1682939
CY2022Q4 mrai Deferred Tax Assets Depreciation
DeferredTaxAssetsDepreciation
262179
CY2021Q4 mrai Deferred Tax Assets Depreciation
DeferredTaxAssetsDepreciation
333501
CY2022Q4 mrai Deferred Tax Assets Operating Lease Assets
DeferredTaxAssetsOperatingLeaseAssets
813972
CY2021Q4 mrai Deferred Tax Assets Operating Lease Assets
DeferredTaxAssetsOperatingLeaseAssets
393985
CY2022Q4 mrai Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
1370631
CY2021Q4 mrai Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
350236
CY2022Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
45388
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
8502772
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2467111
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9982652
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4468123
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1479880
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
2001012
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9982652
CY2022Q4 mrai Inflation Reduction Act Of2022 Minimum Corporate Income Tax Rate
InflationReductionActOf2022MinimumCorporateIncomeTaxRate
0.15
CY2022Q4 mrai Inflation Reduction Act Of2022 Excise Tax On Net Repurchase Of Stock
InflationReductionActOf2022ExciseTaxOnNetRepurchaseOfStock
0.01
CY2022Q4 us-gaap Noncurrent Assets
NoncurrentAssets
22096937
CY2021Q4 us-gaap Noncurrent Assets
NoncurrentAssets
17129023
CY2022Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
0
CY2021Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
297000
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
3201
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
3637
CY2022 mrai Percentage On Monthly Salary Under Severance Pay Law
PercentageOnMonthlySalaryUnderSeverancePayLaw
0.0833
CY2022 us-gaap Severance Costs1
SeveranceCosts1
144896
CY2021 us-gaap Severance Costs1
SeveranceCosts1
132031
CY2022Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
1433327
CY2021Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
897288
CY2022Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1712009
CY2021Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
743038
CY2022Q4 mrai Performance Guarantee Liabilities Current
PerformanceGuaranteeLiabilitiesCurrent
244029
CY2021Q4 mrai Performance Guarantee Liabilities Current
PerformanceGuaranteeLiabilitiesCurrent
418988
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1885351
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
465723
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5274716
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2525037
CY2021Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
4.555821
CY2021Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
24547086
CY2021Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
225000
CY2021Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4
CY2021Q4 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
900000

Files In Submission

Name View Source Status
mrai-20221231_cal.xml Edgar Link unprocessable
0000950170-23-010614-index-headers.html Edgar Link pending
0000950170-23-010614-index.html Edgar Link pending
0000950170-23-010614.txt Edgar Link pending
0000950170-23-010614-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img151732958_0.jpg Edgar Link pending
img151732958_1.jpg Edgar Link pending
img78731545_0.jpg Edgar Link pending
img78731545_1.jpg Edgar Link pending
img78731545_2.jpg Edgar Link pending
img84138877_0.jpg Edgar Link pending
img84138877_1.jpg Edgar Link pending
img84138877_2.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
mrai-20221231.htm Edgar Link pending
mrai-20221231.xsd Edgar Link pending
mrai-ex10_31.htm Edgar Link pending
mrai-ex21_1.htm Edgar Link pending
mrai-ex23_1.htm Edgar Link pending
mrai-ex31_1.htm Edgar Link pending
mrai-ex31_2.htm Edgar Link pending
mrai-ex32_1.htm Edgar Link pending
mrai-ex32_2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
mrai-20221231_def.xml Edgar Link unprocessable
mrai-20221231_lab.xml Edgar Link unprocessable
mrai-20221231_pre.xml Edgar Link unprocessable
mrai-20221231_htm.xml Edgar Link completed
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending